...
首页> 外文期刊>Pakistan journal of medical sciences. >Clinical evaluation of laparoscopic surgery combined with triptorelin acetate in patients with endometriosis and infertility
【24h】

Clinical evaluation of laparoscopic surgery combined with triptorelin acetate in patients with endometriosis and infertility

机译:腹腔镜手术联合醋酸曲普瑞林治疗子宫内膜异位症和不孕症的临床评价

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: To investigate the effects of laparoscopic surgery combined with triptorelin acetate, gestrinone and mifepristone on pregnancy rate, pregnancy outcome, long-term recurrence and adverse reactions in patients with endometriosis (EMT) complicated with infertility. Methods: In this study, 150 patients with EMT and infertility were selected and randomly divided into triptorelin group (group A), gestrinone group (group B) and mifepristone group (group C), with 50 people in each group. Treatment was with gonadotropin-releasing hormone (GnRH-a) after laparoscopic surgery. Results: The success rate of pregnancy in group A was higher than that in group B and C. The incidence of adverse pregnancy outcome was lower than that in group B and C. Kupperman score and subjective symptom score were lower than those in group B and C before treatment. Sex hormone level and CA125 level were significantly better. In the B and C groups and before treatment; the long-term recurrence rate was significantly lower than the B and C groups; the incidence of adverse reactions was similar. Conclusion: Laparoscopic surgery combined with GnRH-a can improve the success and good rate of pregnancy in EMT patients, reduce clinical symptoms, avoid long-term recurrence, and increase the risk of adverse reactions. Triptorelin acetate is superior to gestrinone and mifepristone.
机译:目的:探讨腹腔镜手术联合醋酸曲普瑞林,孕酮和米非司酮对子宫内膜异位症合并不孕症患者的妊娠率,妊娠结局,长期复发及不良反应的影响。方法:选择150例EMT和不育症患者,随机分为曲普瑞林组(A组),孕酮(B组)和米非司酮组(C组),每组50人。腹腔镜手术后用促性腺激素释放激素(GnRH-a)治疗。结果:A组妊娠成功率高于B和C组。不良妊娠结局的发生率低于B和C组。Kupperman评分和主观症状评分低于B组和C组。 C治疗前。性激素水平和CA125水平明显改善。在B组和C组以及治疗之前;长期复发率明显低于B和C组。不良反应的发生率相似。结论:腹腔镜手术联合GnRH-a可提高EMT患者的成功率和妊娠率,减轻临床症状,避免长期复发,增加不良反应发生的风险。醋酸曲普瑞林优于孕酮和米非司酮。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号